Deligoparin sodium
Alternative Names: OP 2000Latest Information Update: 20 Sep 2002
Price :
$50 *
At a glance
- Originator Opocrin
- Class Anti-inflammatories; Anticoagulants; Antithrombotics; Low molecular weight heparins
- Mechanism of Action Factor Xa inhibitors; Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Ulcerative colitis; Unstable angina pectoris
Most Recent Events
- 17 Sep 2002 Discontinued - Phase-III for Ulcerative colitis in USA (SC)
- 29 Aug 2002 Incara has completed patient enrolment in its phase II/III trial of deligoparin for the treatment of ulcerative colitis
- 20 Mar 2002 A study has been added to the Inflammatory Bowel Disorders therapeutic trials section